Consensus recommendations for the use of FEIBA®in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Consensus recommendations for the use of FEIBA®in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery

Published:2012-09-19 Issue:2 Volume:19 Page:294-303
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Rangarajan S.,Austin S.¹,Goddard N. J.²,Négrier C.³,Rodriguez-Merchan E. C.,Stephensen D.⁴,Yee T. T.⁵

Affiliation:

1. St George's Healthcare NHS Trust Haemophilia Centre; St George's Hospital; London; UK

2. Department of Orthopaedic Surgery; Royal Free Hospital NHS Foundation Trust; London; UK

3. Haemostasis Division; Hôpital Edouard Herriot; Lyon; France

4. Kent Haemophilia Centre; Kent & Canterbury Hospital; Canterbury; Kent; UK

5. The Katharine Dormandy Haemophilia Centre and Thrombosis Unit; Royal Free Hospital NHS Foundation Trust; London; UK

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12028/fullpdf

Reference44 articles.

1. Orthopaedic surgery in haemophilia patients with inhibitors: a practical guide to haemostatic, surgical and rehabilitative care;Teitel;Haemophilia,2009

2. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor Eight Bypassing Activity;Négrier;Thromb Haemost,1997

3. Surgery in haemophilic patients with inhibitor: 20 years of experience;Quintana-Molina;Haemophilia,2004

4. Consensus protocol for the use of recombinant activated factor VII [eptagog alfa (activated): Novo Seven] in elective orthopaedic surgery in haemophilic patients with inhibitors;Giangrande;Haemophilia,2009

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hämophilie-Behandlung in Österreich;Wiener klinische Wochenschrift;2024-05

2. A creative approach to managing a case of haemophilia A with inhibitors in a low-resource country: case report;The Journal of Haemophilia Practice;2023-01-01

3. Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies;Blood Advances;2022-12-27

4. Joint replacement for the management of haemophilic arthropathy in patients with inhibitors: A long‐term experience at a single Haemophilia centre;Haemophilia;2020-09-30

5. Cost‐utility analysis of emicizumab prophylaxis in haemophilia A patients with factor VIII inhibitors in Korea;Haemophilia;2020-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3